◀ Back to TLR4
CD14 — TLR4
Pathways - manually collected, often from reviews:
-
BioCarta toll-like receptor pathway:
CD14
→
LPS/TLR4/TLR4/TIRAP/TOLLIP/PKR/MYD88/IRAK/MD-2/CD14 complex (EIF2AK2-MYD88-CD14-TLR4-TOLLIP-TIRAP-IRAK1-LY96)
(modification, collaborate)
-
BioCarta toll-like receptor pathway:
CD14
→
TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2 complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2)
(modification, collaborate)
-
BioCarta toll-like receptor pathway:
None
→
LPS/TLR4/TLR4/TIRAP/TOLLIP/PKR/MYD88/IRAK/MD-2/CD14 complex (EIF2AK2-MYD88-CD14-TLR4-TOLLIP-TIRAP-IRAK1-LY96)
(modification, collaborate)
-
BioCarta toll-like receptor pathway:
LPS/TLR4/TLR4/TIRAP/TOLLIP/PKR/MYD88/IRAK/MD-2/CD14 complex (EIF2AK2-MYD88-CD14-TLR4-TOLLIP-TIRAP-IRAK1-LY96)
→
TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2 complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2)
(modification, collaborate)
-
BioCarta inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages:
LPS/TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2/CD14/LBP complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2-EHHADH-CD14)
(modification, collaborate)
-
BioCarta inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages:
LPS/TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2/CD14/LBP complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2-EHHADH-CD14)
→
CD14/LBP complex (CD14-EHHADH)
(modification, collaborate)
-
BioCarta inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages:
LPS/TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2/CD14/LBP complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2-EHHADH-CD14)
→
TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2 complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2)
(modification, collaborate)
-
BioCarta inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages:
CD14/LBP complex (CD14-EHHADH)
→
TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2 complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2)
(modification, collaborate)
-
BioCarta inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages:
LPS/TLR4/TLR4/TIRAP/TOLLIP/MYD88/IRAK/PKR/MD-2/CD14/LBP complex (IRAK1-LY96-TIRAP-TLR4-TOLLIP-MYD88-EIF2AK2-EHHADH-CD14)
(ceramide biosynthetic process, activates)
-
BioCarta toll-like receptor pathway:
LPS/TLR4/TLR4/TIRAP/TOLLIP/PKR/MYD88/IRAK/MD-2/CD14 complex (EIF2AK2-MYD88-CD14-TLR4-TOLLIP-TIRAP-IRAK1-LY96)
→
TRAF6
(modification, activates)
-
KEGG Toll-like receptor signaling pathway:
CD14
→
TLR4
(protein-protein, activation)
-
KEGG Pathogenic Escherichia coli infection:
CD14
→
TLR4
(protein-protein, activation)
-
KEGG Amoebiasis:
Complex of CD14-TLR2-TLR4
→
NFKB1/RELA
(protein-protein, activation)
-
KEGG Tuberculosis:
CD14
→
TLR4
(protein-protein, activation)
-
NCI Pathway Database Endogenous TLR signaling:
CD14 (CD14)
→
TLR4/MD2 complex (LY96-TLR4)
(modification, activates)
Schaefer et al., J Clin Invest 2005
Evidence: physical interaction
-
NCI Pathway Database Endogenous TLR signaling:
CD14 (CD14)
→
TLR4/MD2 complex (LY96-TLR4)
(modification, activates)
Ohashi et al., J Immunol 2000*, Flohé et al., J Immunol 2003*, Cohen-Sfady et al., J Immunol 2005, Kim et al., Circ Res 2009*
Evidence: mutant phenotype
-
NCI Pathway Database Endogenous TLR signaling:
CD14 (CD14)
→
HSP60/TLR4/MD2 (dimer) complex (TLR4-LY96-HSPD1)
(modification, activates)
Ohashi et al., J Immunol 2000*, Flohé et al., J Immunol 2003*, Cohen-Sfady et al., J Immunol 2005, Kim et al., Circ Res 2009*
Evidence: mutant phenotype
-
NCI Pathway Database Endogenous TLR signaling:
TLR4 (TLR4)
→
CD14 (CD14)
(modification, collaborate)
Guillot et al., J Immunol 2002*, Ohya et al., Biochemistry 2006*
Evidence: mutant phenotype
-
Reactome Reaction:
CD14
→
TLR4
(reaction)
Kishimoto et al., J Biol Chem 2000, da Silva Correia et al., J Biol Chem 2001*, Li et al., Proc Natl Acad Sci U S A 2002, Kalai et al., Cell Death Differ 2002, Donepudi et al., Mol Cell 2003, Fitzgerald et al., Nat Immunol 2003, Jefferies et al., J Biol Chem 2003, Kollewe et al., J Biol Chem 2004, Mori et al., J Biol Chem 2004, Gangloff et al., Trends Biochem Sci 2004*, Kaiser et al., J Immunol 2005, Sato et al., Nat Immunol 2005, Shim et al., Genes Dev 2005, Elner et al., Invest Ophthalmol Vis Sci 2005*, Gray et al., J Biol Chem 2006, Cheng et al., Biochem Biophys Res Commun 2007, Kawagoe et al., J Exp Med 2007, Adhikari et al., Oncogene 2007, Panne et al., J Biol Chem 2007, Piao et al., J Biol Chem 2008, Kawagoe et al., Nat Immunol 2008, Keller et al., Structure 2009, Oberst et al., J Biol Chem 2010, Feoktistova et al., Mol Cell 2011, Estornes et al., Cell Death Differ 2012, Fenton et al., J Leukoc Biol 1998*
-
Reactome Reaction:
CD14
→
TLR4
(indirect_complex)
da Silva Correia et al., J Biol Chem 2001*, Gangloff et al., Trends Biochem Sci 2004*, Elner et al., Invest Ophthalmol Vis Sci 2005*, Husebye et al., EMBO J 2006*, Aki et al., Genes Cells 2008*, Kagan et al., Nat Immunol 2008*, Zanoni et al., Cell 2011*, Chiang et al., J Biol Chem 2012*, Fenton et al., J Leukoc Biol 1998*
-
WikiPathways Pathogenic Escherichia coli infection:
CD14
→
TLR4
(activation)
-
WikiPathways Regulation of toll-like receptor signaling pathway:
CD14
→
TLR4
(activation)
-
WikiPathways Toll-like Receptor Signaling Pathway:
CD14
→
TLR4
(activation)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Filipp et al., Proc Natl Acad Sci U S A 2001
:
sCD14 mediated cellular activation does not require membrane
CD14 expression, depends on a region of CD14 that is not involved in lipopolysaccharide binding, and
requires functional
Toll-like receptor 4
Hijiya et al., Pathobiology 2002
:
These results show that
TLR4 in the
presence of soluble
CD14 plays a major role in the signaling of LPS in endothelial cells of larger vessels
Farnell et al., Dev Comp Immunol 2003
:
Oxidative burst
mediated by
toll like receptors ( TLR ) and
CD14 on avian heterophils stimulated with bacterial toll agonists
Chen et al., J Leukoc Biol 2004
:
When the effect of lipopolysaccharide contamination is abrogated, Hsp65 is unable to activate
Toll-like receptor (TLR)4 in the
presence of
CD14 and MD2
Feng et al., Hepatobiliary Pancreat Dis Int 2003
:
The expressions of CD14 and
TLR4 in KCs induced by LPS were markedly
increased in a dose dependent manner ( 10 mg/L-1 microg/L ) or in a time dependent manner ( 0.5 h-24 h ), with the peaked expression of
CD14 at 3-6 hours
Hirata et al., J Clin Endocrinol Metab 2005
:
We further showed that EECs, not ESCs,
required soluble
CD14 for
TLR4 activation
Lucarelli et al., Eur Cytokine Netw 2004
:
On the other hand,
TLR9 expression was decreased by SiO ( 2 ) nano-particles, and expression of the co-receptor
CD14 was
inhibited by Co nanoparticles
Coats et al., J Immunol 2005
:
Activation of the
TLR4 signaling complex
requires the coordinated function of LPS binding protein (LBP),
CD14 , MD-2, and TLR4
Botero et al., J Endod 2006
:
These results demonstrate that odontoblast-like cells express
CD14 and TLR4, and that LPS induced VEGF expression is
mediated , at least in part, by
TLR4 signaling
Balachandran et al., Int Immunopharmacol 2006
:
Similarly, NF-kappa B directed luciferase expression was enhanced by Immulina treatment when cells were co-transfected with vectors expressing proteins supporting TLR2- (
CD14 and TLR2 ) but not
TLR4- ( CD14, TLR4, and MD-2 ) dependent
activation
Cuschieri et al., Surg Infect (Larchmt) 2007
:
Assembly and
activation of the
TLR4 receptor following LPS binding to
CD14 requires the production of ceramide by acid sphingomyelinase
Whitaker et al., Infect Immun 2008
(Leishmaniasis) :
Activation by P8 PGLC does not occur in the
presence of
TLR4 alone and requires both
CD14 and myeloid differentiation protein 2 for signaling ; this requirement may be responsible for the limited TLR4 response
Lizundia et al., Innate Immun 2008
:
Our findings suggest that human and bovine RSV may activate human and bovine
TLR4 receptors, respectively, in the
presence of both MD2 and
CD14
Roncon-Albuquerque et al., Life Sci 2008
(Fatty Liver...) :
These results suggest that
CD14 mediated
TLR activation might contribute to the cardiovascular and metabolic complications of obesity
Peri et al., Biochem Soc Trans 2010
:
Small molecules developed by our group are described that
inhibit LPS stimulated
TLR4 activation by selectively targeting the
LPS-CD14 interaction
Jia et al., Shanghai Kou Qiang Yi Xue 2011
:
CD14,
TLR4 receptors are involved in P.e-LPS effect and
CD14 , TLR2 and TLR4 receptors are
involved in P.g-LPS effect in mouse osteoblast ... CD14,
TLR4 receptors are involved in P.e-LPS effect and
CD14 , TLR2 and TLR4 receptors are
involved in P.g-LPS effect in mouse osteoblast
Rallabhandi et al., mBio 2012
(Respiratory Syncytial Virus Infections) :
Toll-like receptor 4 (TLR4) , a signaling receptor for structurally diverse microbe associated molecular patterns, is activated by the RSV fusion ( F ) protein and by bacterial lipopolysaccharide (LPS) in a
CD14 dependent manner
Zheng et al., Int Immunopharmacol 2012
(Drug-Induced Liver Injury) :
We also found that GalN treatment induced
TLR4 and CD14 mRNA expression, and LMW significantly
inhibited CD14 mRNA expression
Guo et al., Am J Pathol 2013
:
In conclusion, these studies show for the first time that LPS causes an increase in intestinal permeability via an intracellular mechanism involving
TLR-4 dependent up-regulation of
CD14 membrane expression
Zhou et al., Brain Res 2013
(Brain Ischemia...) :
The expression of
CD14 , a co-receptor of TLR4, was
induced by MCAO, while the expression of
TLR4 remained unchanged
Kim et al., Mol Med 2013
:
We demonstrate that optimal HMGB1 dependent
TLR4 activation in vitro
requires the coreceptor
CD14
Lei et al., J Med Primatol 2013
:
Toll-like receptor ( TLR ) stimulation significantly
increased IDO protein level in
CD14 ( + ), CD56 ( + ), CD1c ( + ), CD11c ( + ), and CD123 ( + ) myeloid cells